🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
AZN.L
LSE
🇬🇧 UK ISA ✓
AstraZeneca PLC
Pharmaceuticals
28Score
DipBuster Score™
£13,214.00
£220 (-1.64%)
Live price · Source: Yahoo
52-Week Position
£10,103.00
55% of range
£15,732.00
Beta
0.223
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.223
52W High£15,732.00
52W Low£10,103.00
🤖
Not a Dip — Score 28/100
Zone: Hold / Watch
🔒 Unlock Pro
Valuation
P/E Ratio—
Mkt CapN/A
52W Position55% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.223
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️
Insider Buys
Track director & CEO open-market purchases
📊
Valuation Analysis
P/E, EV/EBITDA, DCF & NCAV metrics
📈
Financial Charts
Revenue, EBITDA, FCF & balance sheet trends
🤖
AI Analysis
Plain-English explanation of every key metric
Sign up free — charts & fundamentals included
Get financial charts, valuation data, dividends & news for AstraZeneca PLC free. Upgrade to Pro for insider signals & AI analysis.
Sponsored · FCA Regulated Broker
Freetrade
Simple investing app. Free ISA. UK and US stocks. FCA regulated.
Free share when you fund your account
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
18/25
Momentum & Volume
5/25
Quality & Size
5/10
Insider Activity
0/10
Quick Take
⚪
Not a Dip
DipBuster Score: 28/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Ir…
Sector
Pharmaceuticals
Market
🇬🇧 LSE
CEO
Pascal Claude Roland Soriot
Staff
94,300 employees
Website